Adcetris Description

brentuximab vedotin




Full Prescribing Info
Each vial contains 50 mg of brentuximab vedotin.
After reconstitution (see Special precautions for disposal and other handling under Cautions for Usage), each ml contains 5 mg of brentuximab vedotin.
ADCETRIS is an antibody-drug conjugate composed of a CD30-directed monoclonal antibody (recombinant chimeric immunoglobulin G1 (IgG1), produced by recombinant DNA technology in Chinese Hamster ovary cells) that is covalently linked to the antimicrotubule agent monomethyl auristatin E (MMAE).
Excipients with known effect: Each vial contains approximately 13.2 mg of sodium.
Excipients/Inactive Ingredients: Citric acid monohydrate, Sodium citrate dihydrate, α,α-Trehalose dihydrate, Polysorbate 80.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in